{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:07:10Z","timestamp":1789049230636,"version":"build-2803163510"},"reference-count":38,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Shenzhen Medical Research Fund","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Shenzhen Science and Technology Program","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>APOBEC3B (A3B), a key driver of cancer mutagenesis, has emerged as a promising therapeutic target to be ablated to enhance antitumor immunity while reducing intestinal inflammation. Starting from SMC247 (3, 5-diiodotyrosine), a kelp-derived natural product, we identified the optimized analogue SMC247-9 as a potent A3B inhibitor, with an IC50 of 50 pM and KD value of 300 pM. SMC247-9 reduced cellular A3B abundance and promoted IL-15 expression in tumor cells, thereby relieving tumor cell-mediated suppression of CD8+ T cells in an IL-15-dependent manner. In immunocompetent mice, SMC247-9 suppressed tumor growth in the immune checkpoint blockade (ICB)-responsive MC38 model and synergized with anti-PD-L1 in the ICB-resistant TC-1 model. SMC247-9 also attenuated macrophage chemotaxis and ameliorated anti-PD-1-exacerbated DSS-induced colitis-like intestinal inflammation. These findings support A3B-targeted pharmacologic intervention as a strategy to enhance antitumor efficacy while reducing inflammatory toxicity in cancer immunotherapy.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01416","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:02:35Z","timestamp":1786712555000},"page":"20678-20697","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of\na Potent APOBEC3B Inhibitor to Augment\nAntitumor Immunity and Reduce Inflammatory Toxicity"],"prefix":"10.1021","volume":"69","author":[{"given":"Haoming","family":"Ning","sequence":"first","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Yang","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Dong","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Shang","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Chen","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liang","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Qian","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]},{"name":"Zhengzhou University , , ,","place":["Zhengzhou, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuman","family":"Zhou","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-4321","authenticated-orcid":true,"given":"Qingyang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-7100","authenticated-orcid":true,"given":"Yanfeng","family":"Gao","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-sen University , , ,","place":["Shenzhen, China, 518107"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"8","key":"2026091009074486700_cit1","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and\nfuture directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"4","key":"2026091009074486700_cit2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint\ninhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7437","key":"2026091009074486700_cit3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature11881","article-title":"APOBEC3B\nis an enzymatic\nsource of mutation in breast cancer","volume":"494","author":"Burns","year":"2013","journal-title":"Nature"},{"issue":"9","key":"2026091009074486700_cit4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC\ncytidine deaminase mutagenesis pattern is\nwidespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat. Genet."},{"issue":"7","key":"2026091009074486700_cit5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC Enzymes:\nMutagenic Fuel for Cancer Evolution and Heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discovery"},{"issue":"11","key":"2026091009074486700_cit6","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41588-022-01196-8","article-title":"Addressing the benefits\nof inhibiting APOBEC3-dependent mutagenesis in cancer","volume":"54","author":"Petljak","year":"2022","journal-title":"Nat. Genet."},{"issue":"1","key":"2026091009074486700_cit7","doi-asserted-by":"publisher","first-page":"1975386","DOI":"10.1080\/2162402X.2021.1975386","article-title":"Immune inactivation by APOBEC3B enrichment predicts\nresponse to chemotherapy\nand survival in gastric cancer","volume":"10","author":"Xia","year":"2021","journal-title":"OncoImmunology"},{"issue":"29","key":"2026091009074486700_cit8","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1038\/s41388-018-0245-9","article-title":"APOBEC3B and APOBEC mutational signature\nas potential predictive markers for immunotherapy response in non-small\ncell lung cancer","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"2026091009074486700_cit9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41467-020-14568-7","article-title":"APOBEC3B-mediated\ncorruption of the tumor cell immunopeptidome\ninduces heteroclitic neoepitopes for cancer immunotherapy","volume":"11","author":"Driscoll","year":"2020","journal-title":"Nat. Commun."},{"key":"2026091009074486700_cit10","doi-asserted-by":"publisher","first-page":"109042","DOI":"10.1016\/j.bioorg.2025.109042","article-title":"Development\nof APOBEC3B inhibitors:\nRecent advances and perspectives","volume":"165","author":"Zhang","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"11","key":"2026091009074486700_cit11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005503","article-title":"Identification of natural product 3, 5-diiodotyrosine\nas APOBEC3B\ninhibitor to prevent somatic mutation accumulation and cancer progression","volume":"10","author":"Chen","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026091009074486700_cit12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.abb.2017.07.019","article-title":"The distribution and mechanism of\niodotyrosine deiodinase\ndefied expectations","volume":"632","author":"Sun","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"2026091009074486700_cit13","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1182\/blood-2003-01-0183","article-title":"IL-15 induces\nantigen-independent expansion and differentiation of human naive CD8+\nT cells in vitro","volume":"102","author":"Alves","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2026091009074486700_cit14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines\nand the immune response\nto cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"5","key":"2026091009074486700_cit15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.immuni.2021.03.022","article-title":"Redefining macrophage\nand neutrophil biology in the\nmetastatic cascade","volume":"54","author":"Gu\u0308c\u0327","year":"2021","journal-title":"Immunity"},{"issue":"5","key":"2026091009074486700_cit16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.tips.2022.02.007","article-title":"The current\ntoolbox for APOBEC drug discovery","volume":"43","author":"Grillo","year":"2022","journal-title":"Trends Pharmacol.\nSci."},{"issue":"1","key":"2026091009074486700_cit17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41588-023-01592-8","article-title":"The role\nof APOBEC3B in lung tumor evolution and targeted cancer\ntherapy resistance","volume":"56","author":"Caswell","year":"2024","journal-title":"Nat. Genet."},{"issue":"10","key":"2026091009074486700_cit18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41588-023-01504-w","article-title":"APOBEC3B regulates R-loops and promotes transcription-associated\nmutagenesis in cancer","volume":"55","author":"McCann","year":"2023","journal-title":"Nat. Genet."},{"issue":"6","key":"2026091009074486700_cit19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41588-025-02187-1","article-title":"APOBEC3\nmutagenesis drives therapy resistance in breast\ncancer","volume":"57","author":"Gupta","year":"2025","journal-title":"Nat. Genet."},{"issue":"10","key":"2026091009074486700_cit20","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity\ncycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"2026091009074486700_cit21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology Meets Immunology: The Cancer-Immunity Cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"23","key":"2026091009074486700_cit22","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.cell.2022.10.007","article-title":"Macrophages in health\nand disease","volume":"185","author":"Park","year":"2022","journal-title":"Cell"},{"issue":"5","key":"2026091009074486700_cit23","doi-asserted-by":"publisher","first-page":"101531","DOI":"10.1016\/j.xcrm.2024.101531","article-title":"Next-generation anti-PD-L1\/IL-15\nimmunocytokine elicits superior\nantitumor immunity in cold tumors with minimal toxicity","volume":"5","author":"Shi","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"7","key":"2026091009074486700_cit24","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement\nof the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic\ncancer","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"issue":"8","key":"2026091009074486700_cit25","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages\nin intestinal homeostasis\nand inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol.\nHepatol."},{"issue":"10","key":"2026091009074486700_cit26","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1158\/2159-8290.CD-20-0725","article-title":"Induction\nof APOBEC3 Exacerbates DNA Replication\nStress and Chromosomal Instability in Early Breast and Lung Cancer\nEvolution","volume":"11","author":"Venkatesan","year":"2021","journal-title":"Cancer Discovery"},{"issue":"7897","key":"2026091009074486700_cit27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-022-04398-6","article-title":"Mapping\nclustered mutations\nin cancer reveals APOBEC3 mutagenesis of ecDNA","volume":"602","author":"Bergstrom","year":"2022","journal-title":"Nature"},{"issue":"1","key":"2026091009074486700_cit28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","article-title":"CXCR2 chemokine receptor \u2013\na master regulator in cancer and physiology","volume":"30","author":"Lazennec","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"7","key":"2026091009074486700_cit29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.medj.2024.03.015","article-title":"Myeloid-T\ncell interplay and cell state transitions associated with checkpoint\ninhibitor response in melanoma","volume":"5","author":"Schlenker","year":"2024","journal-title":"Med."},{"issue":"2","key":"2026091009074486700_cit30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ccell.2025.01.004","article-title":"Adiponectin\nreduces immune checkpoint inhibitor-induced\ninflammation without blocking anti-tumor immunity","volume":"43","author":"Braun","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"2026091009074486700_cit31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymthe.2022.08.016","article-title":"A novel anti-PD-L1\/IL-15\nimmunocytokine\novercomes resistance to PD-L1 blockade and elicits potent antitumor\nimmunity","volume":"31","author":"Shi","year":"2023","journal-title":"Mol. Ther."},{"issue":"3","key":"2026091009074486700_cit32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2016.08.011","article-title":"Facilitating\nT Cell Infiltration in Tumor Microenvironment Overcomes Resistance\nto PD-L1 Blockade","volume":"30","author":"Tang","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"2026091009074486700_cit33","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.it.2023.10.006","article-title":"Macrophage states: there\u2019s\na method in the madness","volume":"44","author":"Katkar","year":"2023","journal-title":"Trends Immunol."},{"issue":"1","key":"2026091009074486700_cit34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"2026091009074486700_cit35","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41467-023-39173-2","article-title":"Selective oxidative\nprotection leads to tissue topological changes\norchestrated by macrophage during ulcerative colitis","volume":"14","author":"Du","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"2026091009074486700_cit36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting\ncancer-promoting inflammation\u2013have\nanti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat.\nRev. Clin. Oncol."},{"issue":"18","key":"2026091009074486700_cit37","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The Tumor Microenvironment Innately\nModulates Cancer\nProgression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"issue":"7","key":"2026091009074486700_cit38","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1021\/acs.jmedchem.5c03115","article-title":"A Bispecific Peptide\u2013Drug\nConjugate Targeting LAG-3 and PD-L1\nHarnesses Antitumor Immunity of Macrophages and T Cells","volume":"69","author":"Qian","year":"2026","journal-title":"J. Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01416","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20678\/66543713\/acs.jmedchem.6c01416.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20678\/66543713\/acs.jmedchem.6c01416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:12:56Z","timestamp":1789045976000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/17\/20678\/5255293\/Discovery-of-a-Potent-APOBEC3B-Inhibitor-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":38,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01416","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}